Executives of EpiPen maker Mylan will not testify before Congress about its settlement with the Justice Department over allegations it bilked Medicaid, angering a top GOP senator.

Mylan joined the Justice Department in declining to testify at a Nov. 30 Senate hearing on a settlement over Medicaid rebates for the allergy drug whose price was raised by Mylan to about $600 for a two-pack.